SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S. Corbett, Barney S. Graham, Hamilton Bennett et al.|Nature|2020Cited by 1.7k
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S. Corbett, Tracy J. Ruckwardt, Darin K. Edwards et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 143
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgeneraGeoffrey B. Hutchinson, Kizzmekia S. Corbett, Olubukola M. Abiona et al.|Nature Communications|2023Cited by 30
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroupsGeoffrey B. Hutchinson, Kizzmekia S. Corbett, Olubukola M. Abiona et al.|Research Square|2022Cited by 2
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgeneraMcLellan J.S., Graham B.S., Charis Palandjian et al.|UNC Libraries|2023Cited by 0